Sign in
4

Changes in Ownership

Tempest Therapeutics, Inc. Filed Acc 0001415889-25-000806

Options or other derivatives

  • Chief Medical Officer acquired 270,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Whiting Samuel Chief Medical Officer 2025-01-02 Grant or award · Employee Stock Option (right to buy) +270,000 270,000 D
Loading xslF345X05/form4-01062025_050114.xml…